Jackson Hospital Appoints New Board of Trustees and Chief Executive Officer

Renowned Healthcare Experts and Executive Leaders to Direct Hospital Restructuring Charles R. Evans Named Chair of the Board; John Quinlivan Named CEO MONTGOMERY, Ala.–(BUSINESS WIRE)–Jackson Hospital today announced the appointment of a new three-member Board of Trustees and the selection of John Quinlivan as chief executive officer, marking a pivotal step forward in the hospital’s … [Read more…]

New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization

Findings Reinforce QDENGA’s Long-Term Safety Profile and Two-Dose Vaccination Schedule QDENGA is the Longest-Studied Dengue Vaccine and the Only Approved for Use Regardless of Prior Disease Exposure Takeda is Expanding Global Access to QDENGA in Partnership with National Immunization Programs, Private Payors and Public Health Coalitions, with 18.6 Million Doses Distributed in 11 Endemic Countries … [Read more…]

KCAS Bio Strengthens Board of Directors with Appointment of Paul Kirchgraber and Kurt Doyle

OLATHE, Kan.–(BUSINESS WIRE)–KCAS Bio, a leading contract research organization (CRO) specializing in comprehensive bioanalytical and biomarker services, is delighted to announce the appointment of Dr. Paul Kirchgraber and Mr. Kurt Doyle to its Board of Directors. Their addition marks a significant milestone in KCAS Bio’s continued growth and strategic evolution in the global life sciences … [Read more…]

Positive Phase III Data for Genentech’s Gazyva Show Significant Reduction in Disease Activity for Systemic Lupus Erythematosus

– Phase III ALLEGORY study met primary and all key secondary endpoints with Gazyva, an anti-CD20 monoclonal antibody designed for enhanced B cell depletion – – Gazyva has the potential to be a transformative new standard of care for up to 3.4 million people affected by systemic lupus erythematosus (SLE) worldwide – – If approved, … [Read more…]

Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary

Samsung Epis Holdings to be listed on Korea Exchange (KRX) on November 24, 2025 Samsung Epis Holdings to focus on exploring next-generation growth drivers and optimizing business strategies for its subsidiaries ‒Samsung Bioepis and a new company under Samsung Epis Holdings Samsung Bioepis will continue to operate its biosimilar business as a 100% owned subsidiary … [Read more…]

Pan-Mass Challenge Raises Record $78 Million for Dana-Farber Cancer Institute

Athletic Fundraiser Breaks Another Record in Support of Cancer Research and Care BOSTON–(BUSINESS WIRE)–The Pan-Mass Challenge (PMC), the world’s single most successful athletic fundraiser, has announced a $78 million gift for cancer research, treatment and patient care at the top-ranked Dana-Farber Cancer Institute. Since its founding in 1980, the PMC has raised a total of … [Read more…]

Where to Get TMS Therapy in Colorado Springs Starts with Serenity Mental Health Centers

Serenity clinics offer accessible TMS treatment for mental health. COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–Serenity Mental Health Centers, a leader in innovative psychiatric care and one of the fastest-growing mental health providers in the nation, is setting the standard for TMS therapy in Colorado Springs. Serenity’s board-certified psychiatrists and psychiatric mental health nurse practitioners provide full-spectrum mental … [Read more…]

Serenity Mental Health Centers Expands Access in Colorado Springs with FDA-cleared Accelerated Deep TMS Protocol

Patients nationwide can access faster, convenient TMS treatment. COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–Serenity Mental Health Centers, a leader in innovative psychiatric care and one of the fastest-growing mental health providers in the nation, today announced that its patients now have immediate access to the FDA-cleared accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) protocol from BrainsWay for … [Read more…]

Appointment of Yves Decadt as Member of Poxel’s Board of Directors

LYON, France–(BUSINESS WIRE)–Regulatory News: POXEL SA (Euronext : POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today announces the appointment of Yves Decadt as a member of its Board of Directors. Following the governance changes implemented … [Read more…]

TruBridge Announces Third Quarter 2025 Conference Call to Be Held Friday, November 7, 2025

MOBILE, Ala.–(BUSINESS WIRE)–TruBridge, Inc. (NASDAQ: TBRG), a leading provider of revenue cycle management and healthcare technology solutions for rural and community healthcare organizations, today announced that it will release its financial results for the third quarter ended September 30, 2025, on Thursday, November 6, 2025, after the market closes. The Company will host a conference … [Read more…]